Our people

At AstraZeneca, we recognise that our people are our greatest assets and know what’s possible with a talented and diverse team that believes in what science can do.

Home / Our company / Our people

We have more than 83,000 people across the globe and dedicated to push the boundaries of science to deliver life-changing medicines to patients. Meet some of those individuals that are committed to transforming the lives of billions of people around the world.

Scientist working in a lab

Oncology

Within our Oncology business, we strive to advance medicines through robust research and scientific partnerships. With a broad pipeline of next-generation medicines focused on a whole host of various oncology therapies, we’re using personalised technology to redefine oncology care. In this commercial arm of the business, we use a scientific approach to build healthcare strategies that open up access to our innovative and life-improving therapies.
Two laboratory technicians looking at a laptop

BioPharmaceuticals

Across our BioPharmaceuticals Business Unit, we work to build new and effective strategies that help us to continuously enhance quality of life for patients around the world. As the commercial arm for BioPharmaceuticals, we’re dedicated to driving excellence across our core areas of; Cardiovascular, Renal & Metabolic (CVRM), Respiratory & Immunology, as well as Microbial Sciences and Neuroscience. This is how we change the course of modern medicine.
two people in an office meeting

Rare Disease

At AstraZeneca, we enhanced scientific presence in immunology and, through Alexion’s innovative complement-biology platform and robust pipeline, will continue to pioneer the discovery and development of medicines for patients with rare diseases. Rare diseases represent a significant unmet medical need and becomes a high-growth opportunity for the Company.
two laboratory technicians working in a lab

Research and Development

At AstraZeneca, we focus on the discovery, development and commercialisation of prescription medicines in Oncology, BioPharmaceuticals and Rare Disease, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Our R&D groups are unified in their approach, and united in their purpose to deliver life-changing medicines to people who need them most. By collaborating internally and externally, we aim to accelerate the discovery of novel therapies for unmet medical needs.
Enabling functions

In Enabling, we help our global organisation operate seamlessly.
 
Operations

When it comes to our Operations business, delivering on our commitments and ensuring global efficiency is extremely important.
International

Our International region is our largest, most diverse and fastest growing area.
 

Veeva ID: Z4-51286
Date of preparation: December 2022